An auditor opening a peptide vial is not simply checking a sticker. They are testing whether the item’s declared purpose, its documentation and its physical handling all tell the same story. On a UK research peptide label, the phrase For Research Use Only – Not for Human Consumption is the starting point of that story, and for a documented materials audit it carries more weight than most laboratory staff assume.
The RUO Label Functions as a Use-Boundary Control Record
On a vial supplied by Research Sciences, the research-use-only marking is not a decorative disclaimer. It is a use-boundary statement. The shop describes its products as strictly for controlled laboratory and analytical research, and states that they must not be regarded, described, marketed, repackaged, supplied or used as medicines, medical devices, injectables, treatments or food supplements under UK law. Research Sciences presents its labelling position as being in line with MHRA guidance, while making clear that this is its stated position rather than legal advice. An auditor should read the label in that spirit: as the supplier’s declaration of intended use, not as a substitute for the laboratory’s own compliance assessment.
That boundary changes how an item enters the building. A catalogue entry such as MT-1 10mg, TB-500 5mg or GHK-Cu 50mg belongs in the research inventory, under research procurement, research storage and research waste routes. It is not a pharmacy stock line, a clinical consumable or a food supplement. The purchaser is responsible for lawful use, safe handling, storage and disposal, and for compliance with relevant UK regulations including COSHH and laboratory safety standards. They are also responsible for checking that a product is suitable for the intended research application. A documented audit should evidence that responsibility rather than assume it.
Vial labels also carry a reference format that combines the SKU code and the expiry date, for example BPC10-03/27, linking the physical vial to the corresponding certificate. The shop advises quoting that reference when contacting it about documentation. This is precisely the kind of identifier a materials auditor needs: it ties the object in the fridge to a batch record, a certificate and a purchase entry. Where a label is faded, detached or absent, the audit trail is broken even if the vial itself looks intact.
The same logic applies to preparation tools. A free reconstitution calculator is described on product pages and in the FAQs for laboratory research use only, covering milligram, microgram, millilitre and syringe-scale inputs. Used within in-vitro assay planning, it is a convenience; it must not be used for human or veterinary dosing. The materials themselves remain not for human or veterinary use, consumption, administration or clinical application.
Reconciling the Label with the CoA and Batch Paper Trail
The label identifies the item; the certificate of analysis should support the claims made about it. The shop’s FAQs state that every compound includes a CoA covering HPLC analysis for purity and identity, that manufacture is by international partners using solid-phase peptide synthesis, and that batches are independently tested by HPLC before final verification and quality checks in the UK. The About page describes an expanded testing framework covering purity, identity, heavy metals and endotoxin evaluation, presented as a later milestone. These are the shop’s published descriptions, and an auditor should verify the actual batch document rather than relying on the summary.
The homepage at the time of writing lists “≥99% Verified Purity” and “CoAs Janoshik Analytical Reports”, alongside broader lines such as “3,000+ UK Orders” and “24hr UK Delivery”. Those are published marketing statements that should be reconfirmed against the live site and, where purity or identity is concerned, against the CoA that accompanies the specific batch. They should not be reconciled into a single assumed figure. The FAQs note that exact purity is stated on the CoA, which is the correct controlling record for an audit file. For researchers cross-checking published specifications before an audit, the current catalogue and documentation guidance at Peptides uk are a sensible starting point, but the batch CoA remains decisive.
ITR references and packaging traps
Restocked products may carry the same Internal Test Reference (ITR) as earlier stock. An ITR links to associated sample testing reports; it does not confirm that separate deliveries come from the same production lot or that they have had separate independent testing. Vial cap colours and other packaging may vary, and cap colour is not an indicator of identity, analytical quality or manufacturing origin. An audit finding that treats cap colour as a batch identifier is therefore unreliable. The FAQs also note that all peptides contain trace amounts of mannitol, an excipient used for stability during lyophilisation, solubility and protection in storage. That is a formulation note to record, not a reason to reclassify the material.
Practical Audit Scenarios for Storage, Handling and Disposal
Handling guidance is part of the audit evidence because it shows whether the laboratory has respected the RUO boundary in practice. Lyophilised peptides should be stored at –20°C or below, sealed with desiccant and protected from moisture, heat and light. Vials should be allowed to reach room temperature before opening, work should take place in a clean environment, and only the amount required for the experiment should be removed. Repeated freeze–thaw cycles should be avoided. Reconstituted peptides are less stable and should be held at 2–8°C for short-term laboratory use. The MT-1 product page, as an example of how listings are written, sets out storage at −20°C protected from moisture and light before reconstitution and 2–8°C after reconstitution in a research setting.
In-vitro preparation, not clinical preparation
Reconstitution in this context means preparing a working concentration for an in-vitro assay: diluent volume, concentration and aliquot size are experimental variables. They are not clinical instructions. The shop’s calculator and materials are not for medical or clinical use, and the materials are not for human or veterinary use. A useful audit test is to ask whether a preparation record describes an assay plate, a dilution series and a solvent lot, or whether it has drifted into language that belongs in a clinical setting. The former supports a research audit; the latter undermines it.
Procurement, dispatch and disposal evidence
Fulfilment terms belong in the procurement file too. The shop states that all orders are dispatched the next working day via Royal Mail Tracked 24, which usually delivers the following working day as a Royal Mail estimate; tracking is provided after dispatch, and times may vary in peak periods. No returns are accepted once dispatched because of the specialist and perishable nature of the goods, with refunds only for damage, incorrect supply or quality issues under the Refunds & Returns Policy. Payments are described as Pay-By-Bank or Open Banking through providers such as Wallid, regulated by the FCA, with no card payments. Each of these details should be checked against the live terms at the time of ordering and recorded alongside the label reference and CoA.
Common audit findings tend to be documentary rather than dramatic: a vial in a fridge with no legible reference, a CoA folder where the ITR does not match the delivery, a storage log with unexplained freeze–thaw gaps, or a waste route that has not been assessed under COSHH. The RUO label is the first control point against all of these, because it declares what the material is for, what it is not for, and which batch record should be produced when the auditor asks.
Granada flamenco dancer turned AI policy fellow in Singapore. Rosa tackles federated-learning frameworks, Peranakan cuisine guides, and flamenco biomechanics. She keeps castanets beside her mechanical keyboard for impromptu rhythm breaks.